Document is current
Any future updates will be listed below
-
Authors
Doorduijn, Astrid S. http://orcid.org/0000-0003-4161-5514
de van der Schueren, Marian A. E.
van de Rest, Ondine
de Leeuw, Francisca A.
Hendriksen, Heleen M. A.
Teunissen, Charlotte E.
Scheltens, Philip
van der Flier, Wiesje M.
Visser, Marjolein
-
Funding
Funding for this research was provided by:
Nederlandse Organisatie voor Wetenschappelijk Onderzoek (057-14-004)
- License Information
-
More Information
Article History
Received: 5 December 2019
Accepted: 15 September 2020
First Online: 26 September 2020
Ethics approval and consent to participate
: The study was approved by the local Medical Ethical Committee. All participants provided written informed consent for their clinical data to be used for research purposes.
: Not applicable.
: ASD, MAEdvdS, OvdR, FAdL, HMAH, and MV declare that they have no competing interests. CET is a member of the Innogenetics International Advisory Boards of Fujirebio/Innogenetics and Roche. PS has served as consultant for Wyeth-Elan, Genentech, Danone, and Novartis and received funding for travel from Pfizer, Elan, Janssen, and Danone Research. WMvdF performs contract research for Boehringer Ingelheim. Her research programs have been funded by ZonMW, NWO, EU-FP7, Alzheimer Nederland, CardioVascular Onderzoek Nederland, stichting Dioraphte, Gieskes-Strijbis fonds, Boehringer Ingelheim, Piramal Neuroimaging, Roche BV, Janssen Stellar. All funding is paid to her institution.
